List of Aldeyra Therapeutics patents

Patents where

Current Assignee

Name

Aldeyra Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11701331 Toxic aldehyde related diseases and treatment	Patent 11701331 was granted and assigned to Aldeyra Therapeutics on July, 2023 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11701331	July 18, 2023
‌ US Patent 11771664 Toxic aldehyde related diseases and treatment	Patent 11771664 was granted and assigned to Aldeyra Therapeutics on October, 2023 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11771664	October 3, 2023
‌ US Patent 11786518 Ophthalmic formulations and uses thereof	Patent 11786518 was granted and assigned to Aldeyra Therapeutics on October, 2023 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11786518	October 17, 2023
‌ US Patent 11046650 Deuterated compounds and uses thereof	Patent 11046650 was granted and assigned to Aldeyra Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11046650	June 29, 2021
‌ US Patent 11007157 Toxic aldehyde related diseases and treatment	Patent 11007157 was granted and assigned to Aldeyra Therapeutics on May, 2021 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11007157	May 18, 2021
‌ US Patent 10550085 Deuterated compounds and uses thereof	Patent 10550085 was granted and assigned to Aldeyra Therapeutics on February, 2020 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	10550085	February 4, 2020
‌ US Patent 10213395 Toxic aldehyde related diseases and treatment	Patent 10213395 was granted and assigned to Aldeyra Therapeutics on February, 2019 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	10213395	February 26, 2019
‌ US Patent 10588874 Toxic aldehyde related diseases and treatment	Patent 10588874 was granted and assigned to Aldeyra Therapeutics on March, 2020 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	10588874	March 17, 2020
‌ US Patent 11459300 Deuterated compounds and uses thereof	Patent 11459300 was granted and assigned to Aldeyra Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11459300	October 4, 2022
‌ US Patent 10543181 Toxic aldehyde related diseases and treatment	Patent 10543181 was granted and assigned to Aldeyra Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	10543181	January 28, 2020
‌ US Patent 11312692 Polymorphic compounds and uses thereof	Patent 11312692 was granted and assigned to Aldeyra Therapeutics on April, 2022 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11312692	April 26, 2022
‌ US Patent 10414732 Polymorphic compounds and uses thereof	Patent 10414732 was granted and assigned to Aldeyra Therapeutics on September, 2019 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	10414732	September 17, 2019
‌ US Patent 9687481 Toxic aldehyde related diseases and treatment	Patent 9687481 was granted and assigned to Aldeyra Therapeutics on June, 2017 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	9687481	June 27, 2017
‌ US Patent 10202348 Compositions and methods of treating retinal disease	Patent 10202348 was granted and assigned to Aldeyra Therapeutics on February, 2019 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	10202348	February 12, 2019
‌ US Patent 9814701 Compositions and methods for the treatment of macular degeneration	Patent 9814701 was granted and assigned to Aldeyra Therapeutics on November, 2017 by the United States Patent and Trademark Office.		Aldeyra Therapeutics	United States Patent and Trademark Office	9814701	November 14, 2017
‌ US Patent 10426790 Treatment of allergic eye conditions with cyclodextrins	Patent 10426790 was granted and assigned to Aldeyra Therapeutics on October, 2019 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	10426790	October 1, 2019
‌ US Patent 11040039 Treatment of inflammatory disorders	Patent 11040039 was granted and assigned to Aldeyra Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11040039	June 22, 2021
‌ US Patent 11583529 Treatment of inflammatory disorders	Patent 11583529 was granted and assigned to Aldeyra Therapeutics on February, 2023 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11583529	February 21, 2023
‌ US Patent 9265759 Compositions and methods of treating retinal disease	Patent 9265759 was granted and assigned to Aldeyra Therapeutics on February, 2016 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	9265759	February 23, 2016
‌ US Patent 9364471 Compositions and methods of treating retinal disease	Patent 9364471 was granted and assigned to Aldeyra Therapeutics on June, 2016 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	9364471	June 14, 2016
‌ US Patent 10913722 Compositions and methods of treating retinal disease	Patent 10913722 was granted and assigned to Aldeyra Therapeutics on February, 2021 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	10913722	February 9, 2021
‌ US Patent 9896419 Compositions and methods of treating retinal disease	Patent 9896419 was granted and assigned to Aldeyra Therapeutics on February, 2018 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	9896419	February 20, 2018
‌ US Patent 11129823 Combination treatment of ocular inflammatory disorders and diseases	Patent 11129823 was granted and assigned to Aldeyra Therapeutics on September, 2021 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	11129823	September 28, 2021
‌ US Patent 10111862 Traps in the treatment of macular degeneration	Patent 10111862 was granted and assigned to Aldeyra Therapeutics on October, 2018 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	10111862	October 30, 2018
‌ US Patent 9650342 Compositions and methods of treating retinal disease	Patent 9650342 was granted and assigned to Aldeyra Therapeutics on May, 2017 by the United States Patent and Trademark Office.	Aldeyra Therapeutics	Aldeyra Therapeutics	United States Patent and Trademark Office	9650342	May 16, 2017

Results per page:

33 results

0 selected

33 results

0 selected